ANITA GOKHFELD: Open Payments
NPI 1467107136 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,700 in 110 payments from 29 companies in 2025. Trend: 2023 $499 · 2024 $1,130 · 2025 $2,700
Food & beverage: $2,302Education: $368Speaker / faculty: $30
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 16 | $431 |
| Novartis Pharmaceuticals Corporation | 20 | $291 |
| AstraZeneca Pharmaceuticals LP | 6 | $226 |
| E.R. Squibb & Sons, L.L.C. | 8 | $209 |
| GlaxoSmithKline, LLC. | 7 | $167 |
| SOBI, INC | 6 | $161 |
| Gilead Sciences, Inc. | 4 | $157 |
| Incyte Corporation | 2 | $119 |
| PharmaEssentia USA Corporation | 4 | $79 |
| Agios Pharmaceuticals, Inc. | 3 | $73 |
Products named: Trodelvy, ERLEADA, Fabhalta, RYBREVANT, DARZALEX, LUTATHERA, REBLOZYL, Doptelet.
Industry payments across NY — which companies pay providers there.
